Company / EPS (Diluted)
HealthEquity EPS (Diluted) History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.64
FY2026
5-year range
-$0.53 / $0.64
FY2022-FY2026
Trend
+306.5%
vs FY2025
Sector context
#81 of 159
Health Care
What the data says
EPS (Diluted) changed +306% YoY in FY2026, a notable deviation from the 9-year average annual change of -12%.
Based on SEC 10-K filings.
0.64 in FY2026 with a 5-year CAGR of -11.4%.
Improved from $-0.53 to $0.64 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +74.7%
- 5-Year CAGR
- -11.4%
- 10-Year CAGR
- -
Sector benchmark
#81 of 159 in Health CareTop 51% of 159This company $0.64 Sector average $1.67
▼
-61.6% below sector average
Key checks
Key Insights
- In FY2026, eps (diluted) increased 306.5% year-over-year.
- Ranks #81 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | $0.64 | +306.5% |
| FY2025 | -$0.31 | +41.5% |
| FY2024 | -$0.53 | -541.7% |
| FY2023 | $0.12 | -79.3% |
| FY2022 | $0.58 | -50.4% |
| FY2021 | $1.17 | +51.9% |
| FY2020 | $0.77 | +75.0% |
| FY2019 | $0.44 | +57.1% |
| FY2018 | $0.28 | +33.3% |
| FY2017 | $0.21 | +116.7% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026